AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference

Core Insights - AVITA Medical, Inc. is a leading company in therapeutic acute wound care, focusing on innovative solutions for wound healing [3] Group 1: Company Participation - AVITA Medical management will participate in the TD Cowen 46th Annual Health Care Conference in Boston, MA, with Cary Vance as Interim CEO and David O'Toole as CFO [1] - A presentation and fireside chat is scheduled for March 4 at 8:10 a.m. Pacific Time / 11:10 a.m. Eastern Time, with a live and archived webcast available on the company's website [2] Group 2: Product Offerings - The company's flagship product, RECELL, is FDA-approved for treating thermal burn and trauma wounds, utilizing the patient's own skin to create Spray-On Skin™ for enhanced clinical outcomes [3] - In the U.S., AVITA Medical holds exclusive rights to manufacture and distribute PermeaDerm®, a biosynthetic wound matrix, and Cohealyx™, a collagen-based dermal matrix [3] Group 3: International Approvals - RECELL is approved for various applications in international markets, including thermal burn and trauma wounds, and has received CE mark in Europe, TGA registration in Australia, and PMDA approval in Japan [4]